Skip to main content
. 2014 Feb;58(2):713–721. doi: 10.1128/AAC.02147-13

TABLE 5.

Reciprocal UBTs and areas under the 24-h UBT-time curve for nitroxoline and trimethoprim in the 6 volunteers tested

Drug, urine type, and strain UBT (median [range]) for the indicated collection period (h)
AUBT24
0–4 4–8 8–12 12–24
Nitroxoline
    Native urine
        Escherichia coli ATCC 25922 0 (0–2) 0 (0–0) 0 (0–1) 0 (0–0) 0 (0–12)a
        E. coli BN 0.5 (0–8) 0 (0–0) 0 (0–2) 0 (0–2) 2 (0–36)a
        E. coli 1135121 0 (0–0) 0 (0–4) 0 (0–0) 0 (0–0) 0 (0–16)
        Klebsiella pneumoniae 1082 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
        Proteus mirabilis 1057 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
        Staphylococcus saprophyticus Ho94 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
     Urine at pH 5.5
        E. coli ATCC 25922 1 (1–2) 0 (0–1) 0 (0–0) 0 (0–0) 4 (4–12)a,b
        E. coli BN 1 (0–2) 0 (0–2) 0 (0–1) 0 (0–0) 4 (0–16)a
        E. coli 1135121 0 (0–1) 0 (0–1) 0 (0–0) 0 (0–0) 0 (0–8)
        K. pneumoniae 1082 0 (0–2) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–8)a
        P. mirabilis 1057 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
        S. saprophyticus Ho94 0 (0–2) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–8)a
    Urine at pH 8.0
        E. coli ATCC 25922 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)ac
        E. coli BN 0 (0–1) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–4)a
        E. coli 1135121 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
        K. pneumoniae 1082 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
        P. mirabilis 1057 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
        S. saprophyticus Ho94 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)a
Trimethoprim
    Native urine
        E. coli ATCC 25922 96 (32–128) 96 (32–128) 32 (16–128) 64 (64–64) 1,664 (1,280–2,304)a
        E. coli BN 48 (32–128) 128 (32–128) 48 (16–64) 64 (32–64) 1,600 (704–2,048)a
        E. coli 1135121 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–0)
        K. pneumoniae 1082 12 (4–64) 12 (2–16) 8 (2–16) 8 (0–64) 248 (80–928)a
        P. mirabilis 1057 3 (0–16) 3 (0–16) 2 (0–16) 2 (1–64) 54 (12–912)a
        S. saprophyticus Ho94 8 (2–32) 8 (4–16) 6 (2–16) 8 (2–32) 192 (72–640)a
    Urine at pH 5.5
        E. coli ATCC 25922 32 (16–128) 48 (16–64) 24 (8–128) 64 (32–64) 1,088 (736–2,048)a,b
        E. coli BN 24 (8–64) 24 (8–64) 16 (8–64) 48 (16–64) 880 (512–1,408)a,b
        E. coli 1135121 0 (0–1) 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–4)
        K. pneumoniae 1082 4 (1–8) 4 (1–8) 2 (1–4) 6 (2–16) 112 (64–240)a
        P. mirabilis 1057 2 (0–16) 2.5 (0–8) 2 (0–8) 2 (1–32) 48 (12–464)a,b
        S. saprophyticus Ho94 2 (1–16) 2 (1–4) 2 (1–4) 4 (2–16) 74 (40–288)a,b
    Urine at pH 8.0
        E. coli ATCC 25922 128 (64–128) 128 (64–128) 64 (64–128) 64 (64–64) 2,048 (1,792–2,048)a,b
        E. coli BN 96 (32–256) 128 (16–256) 64 (32–256) 64 (32–64) 1,920 (704–3,840)a,b
        E. coli 1135121 0 (0–0) 0 (0–0) 0 (0–0) 0 (0–1) 0 (0–12)
        K. pneumoniae 1082 12 (4–64) 24 (2–32) 8 (2–16) 8 (1–64) 248 (56–1,024)a
        P. mirabilis 1057 3 (0–32) 5 (0–16) 2 (0–16) 3 (1–64) 74 (12–928)a,b
        S. saprophyticus Ho94 16 (8–32) 24 (8–32) 12 (8–16) 32 (8–64) 592 (224–960)a,b
a

Indication of difference (P = 0.1 with the Mann-Whitney U test and P = 0.1 with the median test) for nitroxoline versus trimethoprim in urine at the same pH.

b

Indication of difference for native pH versus pH 8.0 versus pH 5.5 for nitroxoline or trimethoprim.